Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer
Clinical trial NCT04142554 · WITHDRAWN
Trial details
- NCT number
- NCT04142554
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-09-07
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.